Inappropriate antimicrobial use and potential solutions: a Middle Eastern perspective

References

• Okeke IN, Laxminarayan R, Bhutta Z et al. Antimicrobial in developing countries. Part I: recent trends and current status. Lancet Infect. Dis.5, 481–493 (2005).
   PubMed Web of Science ®Google Scholar
• Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc. Natl Acad. Sci. USA96(3), 1152–1156 (1999).
   PubMed Web of Science ®Google Scholar
• Steinke D, Davey P. Association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies. Clin. Infect. Dis.3, S193–S205 (2001).
   Google Scholar
• Scott P, Deye G, Srinivasan A et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin. Infect. Dis.44(12), 1577–1584 (2007).
   PubMed Web of Science ®Google Scholar
• Moore PS, Harrison LH, Teizak EE, Ajello GW, Broome CV. Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA260, 2686–2689 (1988).
   PubMed Web of Science ®Google Scholar
• Mayer L, Reeves M, Al Hamdan N et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within electrophoretic type 37 complex. J. Infect. Dis.185, 1596–1605 (2002).
   PubMed Web of Science ®Google Scholar
• Memish ZA, Balkhy HH, Almuneef MA, Al-Haj-Hussein BT, Bukhari AI, Osoba AO. Carriage of Staphylococcus aureus among Hajj pilgrims. Saudi Med. J.27(9), 1367–1372 (2006).
   PubMedGoogle Scholar
• Alzeer A, Mashlah A, Fakim N et al. Tuberculosis is the commonest cause of pneumonia requiring hospitalization during Hajj (pilgrimage to Makkah). J. Infect.36(3), 303–306 (1998).
   PubMed Web of Science ®Google Scholar
• Wilder-Smith A, Foo W, Earnest A, Paton NI. High risk of Mycobacterium tuberculosis infection during the Hajj pilgrimage. Trop. Med. Int. Health.10(4), 336–339 (2005).
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Antony A, Abed MS. Antimicrobial resistance rates of Enterobacter spp.: a seven-year surveillance study. Med. Princ. Pract.18(2), 100–104 (2009).
   PubMed Web of Science ®Google Scholar
• Strahilevitz J, Engelstein D, Adler A et al. Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005. Antimicrob. Agents Chemother.51, 3001–3003 (2007).
   PubMedGoogle Scholar
• Shibl A, Memish Z, Pelton S. Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt. Int. J. Antimicrob. Agents.33(5), 410, e1–e9 (2009).
   PubMedGoogle Scholar
• Balkhy HH, Memish ZA, Almuneef MA et al. Methicillin-resistant Staphylococcus aureus: a 5-year review of surveillance data in a tertiary care hospital in Saudi Arabia. Infect. Control Hosp. Epidemiol.28(8), 976–982 (2007).
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA. Incidence and epidemiology of methicillin-resistant Staphylococcus aureus infection in a Saudi Arabian Hospital, 1999–2003. Infect. Control Hosp. Epidemiol.27(10), 1137–1139 (2006).
   PubMed Web of Science ®Google Scholar
• Udo EE, Al-Sweih N, Dhar R et al. Surveillance of antibacterial resistance in Staphylococcus aureus isolated in Kuwaiti hospitals. Med. Princ. Pract.17(1), 71–75 (2008).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002–2004. MMWR Morb. Mortal. Wkly Rep.53(45), 1063–1066 (2004).
   PubMedGoogle Scholar
• Van Looveren M, Goossens H; ARPAC Steering Group. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin. Microbiol. Infect.10, 684–704 (2004).
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis.39, 309–317 (2004).
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Mohandhas TX. Prevalence of antimicrobial resistance in Acinetobacter calcoaceticus-baumannii complex in a Saudi Arabian hospital. Infect. Control Hosp. Epidemiol.28(7), 870–872 (2007).
   PubMed Web of Science ®Google Scholar
• El Shafie SS, Alishaq M, Leni Garcia M. Investigation of an outbreak of multidrug-resistant Acinetobacter baumannii in trauma intensive care unit. J. Hosp. Infect.56(2), 101–105 (2004).
   PubMedGoogle Scholar
• Mah MW, Memish ZA, Cunningham G, Bannatyne RM. Outbreak of Acinetobacter baumannii in an intensive care unit associated with tracheostomy. Am. J. Infect. Control.29, 284–288 (2001).
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Antony A. Antimicrobial resistance of Klebsiella pneumoniae in a Saudi Arabian hospital: results of a 6-year surveillance study, 1998–2003. J. Infect. Chemother.13(4), 230–234 (2007).
   PubMedGoogle Scholar
• Al-Lawati AM, Crouch ND, Elhag KM. Antibiotic consumption and development of resistance among Gram-negative bacilli in intensive care units in Oman. Ann. Saudi Med.20, 324–327 (2000).
   PubMedGoogle Scholar
• Fadel R, Dakdouki GK, Kanafani ZA, Araj GF, Kanj SS. Clinical and microbiological profile of urinary tract infection at a tertiary-care center in Lebanon. Infect. Control Hosp. Epidemiol.25, 82–85 (2004).
   PubMedGoogle Scholar
• Tohme A, Karam-Sarkis D, El-Rassi R, Chelala D, Ghayad E. Agents and consequences of nosocomial infections in a Lebanese university hospital: retrospective study over a two-year period. Ann. Med. Interne (Paris)152, 77–83 (2001).
   PubMedGoogle Scholar
• Al-Tawfiq JA. Increasing antibiotic resistance among isolates of Escherichia coli recovered from inpatients and outpatients in a Saudi Arabian hospital. Infect. Control Hosp. Epidemiol.27(7), 748–753 (2006).
   PubMed Web of Science ®Google Scholar
• Yilmaz N, Agus N, Yurtsever SG et al. Prevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey. Med. Sci. Monit.15(11), PI61–P165 (2009).
   PubMedGoogle Scholar
• Al-Dhaheri AS, Al-Niyadi MS, Al-Dhaheri AD, Bastaki SM. Resistance patterns of bacterial isolates to antimicrobials from 3 hospitals in the United Arab Emirates. Saudi Med. J.30(5), 618–623 (2009).
   PubMedGoogle Scholar
• Shamaei M, Marjani M, Chitsaz E et al. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran – eight years of surveillance. Int. J. Infect. Dis.13(5), e236–e240 (2009).
   PubMed Web of Science ®Google Scholar
• Aziz MA, Wright A, Laszlo A et al. Epidemiology of antituberculosis drug resistance (the Global Project on Antituberculosis Drug Resistance Surveillance): an updated analysis. Lancet368, 2142–2154 (2006).
   PubMed Web of Science ®Google Scholar
• Mokaddas E, Ahmad S, Samir I. Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996–2005. Int. J. Tuberc. Lung Dis.12(3), 319–325 (2008).
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Al-Muraikhy AA, Abed MS. Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in a Saudi Arabian hospital: a 15-year study from 1989 to 2003. Chest128(5), 3229–3232 (2005).
   PubMed Web of Science ®Google Scholar
• Kardas P, Devine S, Golembesky A, Roberts C. A systematic review and meta-analysis of misuse of antibiotic therapies in the community. Int. J. Antimicrob. Agents.26(2), 106–113 (2005).
   PubMed Web of Science ®Google Scholar
• Al-Hajjaj MS, Al-Khatim IM. High rate of non-compliance with anti-tuberculosis treatment despite a retrieval system: a call for implementation of directly observed therapy in Saudi Arabia. Int. J. Tuberc. Lung Dis.4, 345–349 (2000).
   PubMed Web of Science ®Google Scholar
• Samman Y, Krayem A, Haidar M et al. Treatment outcome of tuberculosis among Saudi nationals: role of drug resistance and compliance. Clin. Microbiol. Infect.9(4), 289–294 (2003).
   PubMed Web of Science ®Google Scholar
• Al-Azzam SI, Al-Husein BA, Alzoubi F, Masadeh MM, Al-Horani MA. Self-medication with antibiotics in Jordanian population. Int. J. Occup. Med. Environ. Health20(4), 373–380 (2007).
   PubMedGoogle Scholar
• Al-Bakri AG, Bustanji Y, Yousef AM. Community consumption of antibacterial drugs within the Jordanian population: sources, patterns and appropriateness. Int. J. Antimicrob. Agents.26(5), 389–395 (2005).
   PubMed Web of Science ®Google Scholar
• Amidi S, Solter S, Rashidian B, Zokaian AR, Razmjoian F. Antibiotic use and abuse among physicians in private practice in Shiraz, Iran. Med. Care13(4), 341–345 (1975).
   PubMedGoogle Scholar
• Sarahroodi S, Arzi A. Self medication with antibiotics, is it a problem among Iranian college students in Tehran?. J. Biol. Sci.9, 829–832 (2009).
   Google Scholar
• Al-Ghamdi MS. Empirical treatment of uncomplicated urinary tract infection by community pharmacist in the Eastern province of Saudi Arabia. Saudi Med. J.22, 1105–1108 (2001).
   PubMed Web of Science ®Google Scholar
• Azab AS. Public knowledge, attitude and practice towards antibiotics use in Riyadh City. Saudi Med. J.21(8), 784–785 (2000).
   PubMedGoogle Scholar
• Koura MR, Khairy AE, Abdel-Aal NM, Deghedi B, Sabra AA. Quality assessment of the primary health care services provided for ARI control in Alexandria. J. Egypt Public Health Assoc.74, 275–296 (1999).
   PubMedGoogle Scholar
• Najdi AN, Khuffash FA, R’Shaid WA, Ateeqi WA. Antibiotic misuse in a paediatric teaching department in Kuwait. Ann. Trop. Paediatr.8(3), 145–148 (1988).
   PubMed Web of Science ®Google Scholar
• el-Gilany AH. Acute respiratory infections in primary health care centers in northern Saudi Arabia. East Mediterr. Health J.6(5–6), 955–960 (2000).
   PubMedGoogle Scholar
• Senok AC, Ismaeel AY, Al-Qashar FA, Agab WA. Pattern of upper respiratory tract infections and physicians’ antibiotic prescribing practices in Bahrain. Med. Princ. Pract.18(3), 170–174 (2009).
   PubMed Web of Science ®Google Scholar
• Al-Mustafa ZH, Al-Ghamdi MS. Use of antibiotics in the poultry industry in Saudi Arabia: implications for public health. Ann. Saudi Med.22(1–2), 4–7 (2002).
   PubMedGoogle Scholar
• Al-Ghamdi MS, Al-Mustafa ZH, El-Morsy F, Al-Faky A, Haider I, Essa H. Residues of tetracycline compounds in poultry products in the eastern province of Saudi Arabia. Public Health114(4), 300–304 (2000).
   PubMed Web of Science ®Google Scholar
• Dellinger EP, Gross PA, Barrett TL et al.; Infectious Diseases Society of America. Quality standards for antimicrobial prophylaxis in surgical procedures. Clin. Infect. Dis.18, 422–427 (1994).
   PubMed Web of Science ®Google Scholar
• Askarian M, Moravveji AR, Mirkhani H, Namazi S, Weed H. Adherence to American Society of Health-System Pharmacists surgical antibiotic prophylaxis guidelines in Iran. Infect. Control Hosp. Epidemiol.27(8), 876–878 (2006).
   PubMedGoogle Scholar
• Askarian M, Assadian O, Safaee G, Golkar A, Namazi S, Movahed MR. Vancomycin use in a large teaching hospital in Shiraz, Islamic Republic of Iran, 2003. East Mediterr. Health J.13(5), 1195–1201 (2007).
   PubMedGoogle Scholar
• al Harbi M. Antimicrobial prophylactic practice in surgical patients. East Afr. Med. J.75(12), 703–707 (1998).
   PubMedGoogle Scholar
• Dib JG, Al-Tawfiq JA, Al Abdulmohsin S, Mohammed K, Jenden PD. Improvement in vancomycin utilization in adults in a Saudi Arabian Medical Center using the Hospital Infection Control Practices Advisory Committee guidelines and simple educational activity. J. Infect. Public Health2(3), 141–146 (2009).
   PubMedGoogle Scholar
• el-Teheawy MM, el-Bokl MA, Abd el-Fattah SA, Sabbour MS. The pattern of antimicrobial use in general hospitals in Egypt. Chemioterapia7(6), 387–392 (1988).
   PubMedGoogle Scholar
• Bilal NE, Gedebou M, Al-Ghamdi S. Endemic nosocomial infections and misuse of antibiotics in a maternity hospital in Saudi Arabia. APMIS.110(2), 140–147 (2002).
   PubMed Web of Science ®Google Scholar
• Al-Ghamdi S, Gedebou M, Bilal NE. Nosocomial infections and misuse of antibiotics in a provincial community hospital, Saudi Arabia. J. Hosp. Infect.50(2), 115–121 (2002).
   PubMed Web of Science ®Google Scholar
• Borg MA, Zarb P, Ferech M, Goossens H; ARMed Project Group. Antibiotic consumption in southern and eastern Mediterranean hospitals: results from the ARMed project. J. Antimicrob. Chemother.62(4), 830–836 (2008).
   PubMed Web of Science ®Google Scholar
• MacPherson DW, Gushulak BD, Baine WB et al. Population mobility, globalization, and antimicrobial drug resistance. Emerg. Infect. Dis.15(11), 1727–1732 (2009).
   PubMed Web of Science ®Google Scholar
• Barbosa TM, Levy SB. The impact of antibiotic use on resistance development and persistence. Drug Resist. Updat.3, 303–311 (2000).
   PubMed Web of Science ®Google Scholar
• Boucher HW, Talbot GH, Bradley JS et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis.48(1), 1–12 (2009).
   PubMed Web of Science ®Google Scholar
• Harrison PF, Lederberg J (Eds). Antimicrobial Resistance Issues and Options, Workshop Report. Washington National Academy Press, WA, USA (1998).
   Google Scholar
• FDA, Compliance Policy Guide 7126.06.1986. Extra Label and Use of New Animal Drugs in Food Producing Animals, FDA, MD, USA (1986).
   Google Scholar
• Veterinary Medicines Directorate: list of pharmacologically active substances for which maximum residue limits have been fixed. Regulation 2377/90, Annex I, VMD. European Commission, Brussels, Belgium, 22 October 1997.
   Google Scholar
• FAO/WHO. 34th Report of the Joint FAO/WHO Expert Committee on Food Additives, Evaluation of Certain Veterinary Drug Residues in Food. WHO/FAO Tech. Rep. Ser.788, 1 (1989).
   PubMedGoogle Scholar
• FAO/WHO 36th Report of the Joint FAO/WHO Expert Committee on Food Additives. Evaluation of Certain Veterinary Drug Residues in Food. WHO/FAO Tech. Rep. Ser.799, 1 (1990).
   PubMedGoogle Scholar
• Gilbert JM, White DG, McDermott PF. The US national resistance monitoring system. Future Microbiol.2(5), 493–500 (2007).
   PubMed Web of Science ®Google Scholar
• Song JH, Lee NY, Ichiyama S et al. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin. Infect. Dis.28, 1206–1211 (1999).
   PubMed Web of Science ®Google Scholar
• Song JH, Chang HH, Suh JY et al. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). J. Antimicrob. Chemother.53, 457–463 (2004).
   PubMed Web of Science ®Google Scholar
• Sabuncu E, David J, Bernède-Bauduin C et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002–2007. PLoS Med.6, e1000084(2009).
   PubMed Web of Science ®Google Scholar
• Okeke IN, Klugman KP, Bhutta ZA et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect. Dis.5(9), 568–580 (2005).
   PubMed Web of Science ®Google Scholar
• Scott A, Komjathy SF, Hu BT et al. Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults. Vaccine25, 6164–6166 (2007).
   PubMed Web of Science ®Google Scholar
• Wasfy MO, Pimentel G, Abdel-Maksoud M et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998–2003. J. Antimicrob. Chemother.55, 958–964 (2005).
   PubMedGoogle Scholar
• Mokaddas EM, Rotimi VO, Albert MJ. Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention. Clin. Vaccine Immunol.15, 203–207 (2008).
   PubMed Web of Science ®Google Scholar
• Whitney CG, Farley MM, Hadler J et al. Decline in invasive pneumococcal disease after the introduction of protein polysaccharide conjugate vaccine. N. Engl. J. Med.348, 1737–1746 (2003).
   PubMed Web of Science ®Google Scholar
• Memish ZA, Arabi YM, Ahmed QA, Shibl AM, Niederman MS; GCC CAP Working Group. Executive summary of the Gulf Cooperation Council practice guidelines for the management of community-acquired pneumonia. J. Chemother.19(Suppl. 1), 7–11 (2007).
   PubMedGoogle Scholar
• Memish ZA, Ahmed QA, Arabi Y, Shibl AM, Niederman MS; GCC CAP Working Group. Rationale for producing evidence-based guidelines for community-acquired pneumonia in the Gulf Corporation Council. J. Chemother.19(Suppl. 1), 13–16 (2007).
   PubMedGoogle Scholar
• Memish ZA, Arabi YM, Ahmed QA, Shibl AM, Niederman MS; GCC CAP Working Group. Management and prevention strategies for community-acquired pneumonia in the Gulf Corporation Council. J. Chemother.19(Suppl. 1), 33–46 (2007).
   PubMedGoogle Scholar
• Al Jarousha AMK, El Jadba AHN, Al Affifi AS, El Qouqa IA. Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine. Int J. Infect. Dis.13(5), 623–628 (2009).
   PubMedGoogle Scholar
• Wilks M, Wilson A, Warwick S et al. Control of an intensive care unit (ICU) without closing the ICU or placing patients in isolation. Infect. Control Hosp. Epidemiol.27, 654–658 (2006).
   PubMed Web of Science ®Google Scholar
• Iseman MD. Directly observed therapy, patient education and combined drug formulations: complementary, not alternative, strategies in tuberculosis control. Tubercle Lung Dis.77, 101(1996).
   PubMedGoogle Scholar
• Salomon N, Perlman DC, Rubenstein A, Mandelman D, Mc-Kinley FW, Yancovitz SR. Implementation of universal directly observed therapy at a New York City hospital and evaluation of an out-patient directly observed therapy program. Int. J. Tuberc. Lung Dis.1, 397–404 (1997).
   PubMedGoogle Scholar